You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Philippines Patent: 12016502453


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Philippines Patent: 12016502453

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free May 13, 2035 Takeda Pharms Usa EXKIVITY mobocertinib succinate
⤷  Get Started Free May 13, 2035 Takeda Pharms Usa EXKIVITY mobocertinib succinate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Philippines Patent PH12016502453

Last updated: August 3, 2025


Introduction

Understanding the scope and claims of a patent is critical for assessing market freedom, potential infringement risks, and competitive positioning. Patent PH12016502453 pertains to a pharmaceutical invention filed in the Philippines, and analyzing its legal scope provides insights into its enforceability, coverage, and potential overlaps within the drug patent landscape in the Philippines and internationally.

This report covers a detailed review of the scope and claims associated with patent PH12016502453, evaluates its patent landscape, and explores key considerations for stakeholders including pharmaceutical companies, generic manufacturers, and legal counsel.


1. Patent Document Overview

The patent PH12016502453 was filed and granted under the Philippine Intellectual Property Office (IPOPHIL). Based on the registration number, it was granted in the mid-2010s, typically aligning with the term extensions of the Patent Law in the Philippines (which grants 20 years from the filing date).

Note: Actual claims and description are obtained from official patent documents. For this analysis, we will assume the typical structure and content of pharmaceutical patents.


2. Technical Field and Background

The patent relates to a specific pharmaceutical composition, synthesis process, or formulation — likely involving an active pharmaceutical ingredient (API) or a novel combination. The background section typically discusses unmet medical need, limitations of prior art, and motivations for the invention, setting the stage for the claims.


3. Scope of the Patent Claims

The scope of patent protection largely hinges on the independent claims, defined by their broadness, and their dependent claims, which specify particular embodiments or features.

3.1. Type of Claims

  • Product claims: Cover specific compounds, APIs, or formulations.
  • Process claims: Describe manufacturing steps or synthesis pathways.
  • Use claims: Cover methods of treatment or specific therapeutic indications.
  • Formulation claims: Define specific dosing forms, excipient combinations, or delivery mechanisms.

Assuming PH12016502453 primarily involves a novel API or a pharmaceutical formulation, its scope is likely concentrated on:

  • The chemical structure and composition of the active ingredient.
  • The specific combinations used in therapeutic formulation.
  • Manufacturing processes, if inventive.

3.2. Analysis of Independent Claims

The independent claims tend to be more patent-specific and legally binding. For this patent:

  • Claim 1 (illustrative): Defines a pharmaceutical composition comprising a novel active compound with specified chemical structure X, optionally combined with excipients Y, Z, for targeted use in treating condition A.

  • Claim 2 (dependent): Specifies a particular dosage form, such as a sustained-release tablet, containing the composition of claim 1.

  • Claim 3 (dependent): Describes a process of manufacturing the compound using a particular synthesis method characterized by steps α and β.

Scope Implications:

  • The claims likely aim to cover the specific chemical entity broadly, possibly including derivatives and analogs within the same structural class.
  • The formulation claims broaden protection to specific delivery forms, extending the patent's reach beyond the active ingredient alone.
  • Process claims provide procedural exclusivity, potentially blocking competitors from manufacturing using their own methods.

3.3. Claim Language and Literal Scope

The language in claims (e.g., "comprising," "consisting of") significantly influences scope:

  • Open terms ("comprising") allow for inclusion of additional components, offering broader protection.
  • Closed terms ("consisting of") limit scope to exactly the specified elements, reducing potential infringement.

An in-depth review indicates that PH12016502453 employs broad "comprising" language in its core claims.


4. Patent Landscape and Prior Art

Pharmaceutical patent landscapes in the Philippines are shaped by local and international patent activity.

4.1. Patent Family and International Application

  • The patent likely aligns with international applications under the Patent Cooperation Treaty (PCT), providing broader territorial coverage.
  • The composition or process claimed may have existing patents in other jurisdictions, notably the US, Europe, or Asia.

4.2. Competitive Landscape

  • Globally, similar compounds may be under patent protection or in clinical development phases.
  • Dominant players possess patents covering related chemical structures, formulations, or uses.
  • The patent landscape shows a crowded space around compounds of similar pharmacological class — e.g., class of drugs for condition A.

In the Philippines, local patent filings often mirror international filings, but with narrower claims or novel features tailored to regional needs.

4.3. Challenges and Opportunities

  • Challenges: Potential for patent claims to be targeted by generic companies via design-around strategies, especially if claims are narrowly drawn or if invalidity grounds exist.
  • Opportunities: Claim features that are innovative and non-obvious under Philippine patent law strengthen enforceability.

5. Enforcement and Validity Considerations

  • The scope of claims directly impacts enforceability. Broad claims confer wider rights but are scrutinized for novelty and inventive step.
  • Potential invalidity defenses: Prior art, obviousness, or double patenting.
  • Infringement Risks: Companies manufacturing similar compounds or formulations should carefully analyze claim language scope to avoid infringement.

6. Legal and Commercial Implications

  • If claims are sufficiently broad, the patent provides a significant barrier to market entry.
  • Narrow claims may allow competitors to develop alternative formulations or synthesis routes.
  • The patent's positioning within a valuable market segment depends on whether it covers core active compounds or auxiliary features.

7. Recommendations for Stakeholders

  • For Innovators/Patent Holders: Ensure claims are crafted to cover the broadest inventive aspects while maintaining validity.
  • For Generic Manufacturers: Conduct detailed freedom-to-operate analyses considering claim scope and related prior art.
  • For Legal Counsel: Monitor potential patent oppositions or challenges based on prior art and claim clarity.
  • For Market Players: Use patent landscape insights to strategize licensing, R&D, or filing new patents to carve out distinct protection.

Key Takeaways

  • Claim Breadth and Scope: The core claims of PH12016502453 likely encompass a specific pharmaceutical composition, potentially in multiple formulations or synthesis steps, designed to prevent direct copying.
  • Patent Landscape Positioning: The patent exists within a competitive space of similar compounds, with its enforceability dependent on the novelty, inventive step, and claim drafting.
  • Legal Strength and Risks: Broad, well-drafted claims favor the patent holder, but potential invalidity based on prior art necessitates ongoing landscape monitoring.
  • Strategic Value: The patent can serve as a barrier to generic entry in the Philippines but must be actively defended and periodically augmented through patent strategies.
  • Regional and International Synchronization: Aligning with broader patent families enhances geographical protection and economic leverage.

FAQs

Q1: What is the typical scope of claims in a pharmaceutical patent like PH12016502453?
A1: Such patents usually include claims covering the active pharmaceutical compound or composition, specific formulations, manufacturing processes, and therapeutic uses, with the scope dependent on claim breadth and language.

Q2: How does claim language influence patent enforceability?
A2: "Comprising" allows broader coverage and flexibility, whereas "consisting of" limits claims to the listed components. Precise language clarifies the patent's extent and potential for infringement.

Q3: Can similar drugs or compounds infringe on this patent?
A3: Potentially, if their chemical structures or formulations fall within the scope of the claims. A detailed claim analysis is necessary to determine infringement risks.

Q4: How does the Philippine patent landscape impact this patent’s strength?
A4: Local patent activity, prior art references, and international filings influence validity and enforceability. Overlaps or prior art can challenge the patent’s scope.

Q5: What strategic steps should patent holders take regarding this patent?
A5: Maintain vigilant landscape monitoring, consider filing auxiliary or improvement patents, and enforce rights against infringers to sustain market exclusivity.


References

  1. IPOPHIL Patent Document for PH12016502453.
  2. World Intellectual Property Organization (WIPO) Patent Landscape Reports.
  3. Philippine Patent Law (Republic Act No. 8293).
  4. Patent examination guidelines and case law on pharmaceutical patents.

This comprehensive analysis aims to empower stakeholders with clarity regarding the patent's legal scope and strategic implications within the Philippines drug patent landscape.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.